Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 68 entries
Sorted by: Best Match Show Resources per page
The Cell Wall Protein Ecm33 of Candida albicans is Involved in Chronological Life Span, Morphogenesis, Cell Wall Regeneration, Stress Tolerance, and Host-Cell Interaction.

Frontiers in microbiology

Gil-Bona A, Reales-Calderon JA, Parra-Giraldo CM, Martinez-Lopez R, Monteoliva L, Gil C.
PMID: 26870022
Front Microbiol. 2016 Feb 02;7:64. doi: 10.3389/fmicb.2016.00064. eCollection 2016.

Ecm33 is a glycosylphosphatidylinositol-anchored protein in the human pathogen Candida albicans. This protein is known to be involved in fungal cell wall integrity (CWI) and is also critical for normal virulence in the mouse model of hematogenously disseminated candidiasis,...

Cite
Gil-Bona A, Reales-Calderon JA, Parra-Giraldo CM, et al. The Cell Wall Protein Ecm33 of Candida albicans is Involved in Chronological Life Span, Morphogenesis, Cell Wall Regeneration, Stress Tolerance, and Host-Cell Interaction. Front Microbiol. 2016;7:64doi: 10.3389/fmicb.2016.00064.
Gil-Bona, A., Reales-Calderon, J. A., Parra-Giraldo, C. M., Martinez-Lopez, R., Monteoliva, L., & Gil, C. (2016). The Cell Wall Protein Ecm33 of Candida albicans is Involved in Chronological Life Span, Morphogenesis, Cell Wall Regeneration, Stress Tolerance, and Host-Cell Interaction. Frontiers in microbiology, 764. https://doi.org/10.3389/fmicb.2016.00064
Gil-Bona, Ana, et al. "The Cell Wall Protein Ecm33 of Candida albicans is Involved in Chronological Life Span, Morphogenesis, Cell Wall Regeneration, Stress Tolerance, and Host-Cell Interaction." Frontiers in microbiology vol. 7 (2016): 64. doi: https://doi.org/10.3389/fmicb.2016.00064
Gil-Bona A, Reales-Calderon JA, Parra-Giraldo CM, Martinez-Lopez R, Monteoliva L, Gil C. The Cell Wall Protein Ecm33 of Candida albicans is Involved in Chronological Life Span, Morphogenesis, Cell Wall Regeneration, Stress Tolerance, and Host-Cell Interaction. Front Microbiol. 2016 Feb 02;7:64. doi: 10.3389/fmicb.2016.00064. eCollection 2016. PMID: 26870022; PMCID: PMC4735633.
Copy Download .nbib Format: NLM
LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds.

Cytotechnology

Specian AF, Serpeloni JM, Tuttis K, Ribeiro DL, Cilião HL, Varanda EA, Sannomiya M, Martinez-Lopez W, Vilegas W, Cólus IM.
PMID: 27344148
Cytotechnology. 2016 Dec;68(6):2729-2744. doi: 10.1007/s10616-016-9998-6. Epub 2016 Jun 25.

Brazilian flora biodiversity has been widely investigated to identify effective and safe phytotherapeutic compounds. Among the investigated plant species, the Byrsonima genus exhibits promising biological activities. This study aimed at evaluating the cytotoxicity of B. correifolia, B. verbascifolia, B....

Cite
Specian AF, Serpeloni JM, Tuttis K, et al. LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds. Cytotechnology. 2016;68(6):2729-2744doi: 10.1007/s10616-016-9998-6.
Specian, A. F., Serpeloni, J. M., Tuttis, K., Ribeiro, D. L., Cilião, H. L., Varanda, E. A., Sannomiya, M., Martinez-Lopez, W., Vilegas, W., & Cólus, I. M. (2016). LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds. Cytotechnology, 68(6), 2729-2744. https://doi.org/10.1007/s10616-016-9998-6
Specian, Ana Flávia L, et al. "LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds." Cytotechnology vol. 68,6 (2016): 2729-2744. doi: https://doi.org/10.1007/s10616-016-9998-6
Specian AF, Serpeloni JM, Tuttis K, Ribeiro DL, Cilião HL, Varanda EA, Sannomiya M, Martinez-Lopez W, Vilegas W, Cólus IM. LDH, proliferation curves and cell cycle analysis are the most suitable assays to identify and characterize new phytotherapeutic compounds. Cytotechnology. 2016 Dec;68(6):2729-2744. doi: 10.1007/s10616-016-9998-6. Epub 2016 Jun 25. PMID: 27344148; PMCID: PMC5101344.
Copy Download .nbib Format: NLM
beta-Thalassaemia Major in a Spanish Patient due to a Compound Heterozygosity for CD39 C --> T/-28 A --> C.

Advances in hematology

Gamarra S, Garcia-Effron G, Monteserin C, Lopez-Villar I, Gilsanz F, Martinez-Lopez J.
PMID: 19960060
Adv Hematol. 2009;2009:476342. doi: 10.1155/2009/476342. Epub 2009 Jul 28.

A Spanish male patient with beta-thalassaemia major was studied. Compound heterozygosity was found for one of the most common beta-globin gene mutations in the Spanish population (codon 39 C --> T) and for a mutation in the TATA box...

Cite
Gamarra S, Garcia-Effron G, Monteserin C, et al. beta-Thalassaemia Major in a Spanish Patient due to a Compound Heterozygosity for CD39 C --> T/-28 A --> C. Adv Hematol. 2009;2009:476342doi: 10.1155/2009/476342.
Gamarra, S., Garcia-Effron, G., Monteserin, C., Lopez-Villar, I., Gilsanz, F., & Martinez-Lopez, J. (2009). beta-Thalassaemia Major in a Spanish Patient due to a Compound Heterozygosity for CD39 C --> T/-28 A --> C. Advances in hematology, 2009476342. https://doi.org/10.1155/2009/476342
Gamarra, Soledad, et al. "beta-Thalassaemia Major in a Spanish Patient due to a Compound Heterozygosity for CD39 C --> T/-28 A --> C." Advances in hematology vol. 2009 (2009): 476342. doi: https://doi.org/10.1155/2009/476342
Gamarra S, Garcia-Effron G, Monteserin C, Lopez-Villar I, Gilsanz F, Martinez-Lopez J. beta-Thalassaemia Major in a Spanish Patient due to a Compound Heterozygosity for CD39 C --> T/-28 A --> C. Adv Hematol. 2009;2009:476342. doi: 10.1155/2009/476342. Epub 2009 Jul 28. PMID: 19960060; PMCID: PMC2778560.
Copy Download .nbib Format: NLM
Del Nido Cardioplegia Versus Cold Blood Cardioplegia in Adult Cardiac Surgery: Protocol for a Randomized Controlled Trial.

JMIR research protocols

Garcia-Suarez J, Garcia Fernandez J, Sanz S, Martinez Lopez D, Reques L, Forteza Gil A.
PMID: 32673265
JMIR Res Protoc. 2020 Jul 14;9(7):e17826. doi: 10.2196/17826.

BACKGROUND: The use of cardioplegia solutions as a myocardial protection technique is essential during cardiac surgery with cardiopulmonary bypass. The del Nido cardioplegia solution (DNS) has been widely used as a myocardial preservation technique for pediatric patients undergoing cardiac...

Cite
Garcia-Suarez J, Garcia Fernandez J, Sanz S, et al. Del Nido Cardioplegia Versus Cold Blood Cardioplegia in Adult Cardiac Surgery: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020;9(7):e17826doi: 10.2196/17826.
Garcia-Suarez, J., Garcia Fernandez, J., Sanz, S., Martinez Lopez, D., Reques, L., & Forteza Gil, A. (2020). Del Nido Cardioplegia Versus Cold Blood Cardioplegia in Adult Cardiac Surgery: Protocol for a Randomized Controlled Trial. JMIR research protocols, 9(7), e17826. https://doi.org/10.2196/17826
Garcia-Suarez, Jessica, et al. "Del Nido Cardioplegia Versus Cold Blood Cardioplegia in Adult Cardiac Surgery: Protocol for a Randomized Controlled Trial." JMIR research protocols vol. 9,7 (2020): e17826. doi: https://doi.org/10.2196/17826
Garcia-Suarez J, Garcia Fernandez J, Sanz S, Martinez Lopez D, Reques L, Forteza Gil A. Del Nido Cardioplegia Versus Cold Blood Cardioplegia in Adult Cardiac Surgery: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020 Jul 14;9(7):e17826. doi: 10.2196/17826. PMID: 32673265; PMCID: PMC7388037.
Copy Download .nbib Format: NLM
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development.

Blood

Alameda D, Goicoechea I, Vicari M, Arriazu E, Nevone A, Rodriguez S, Lasa M, Puig N, Cedena MT, Alignani D, Garate S, Lara-Astiaso D, Vilas-Zornoza A, Sarvide S, Ocio EM, Lecumberri R, Garcia de Coca A, Labrador J, Gonzalez ME, Palomera L, Gironella M, Cabañas V, Casanova M, Oriol A, Krsnik I, Perez-Montaña A, de la Rubia J, de la Puerta JE, de Arriba F, Fazio VM, Martinez-Lopez J, Lahuerta JJ, Mateos MV, Odero MD, Prosper F, Weiner A, Amit I, Nuvolone M, San Miguel JF, Paiva B.
PMID: 34133718
Blood. 2021 Oct 28;138(17):1583-1589. doi: 10.1182/blood.2020009754.

Although light-chain amyloidosis (AL) and multiple myeloma (MM) are characterized by tumor plasma cell (PC) expansion in bone marrow (BM), their clinical presentation differs. Previous attempts to identify unique pathogenic mechanisms behind such differences were unsuccessful, and no studies...

Cite
Alameda D, Goicoechea I, Vicari M, et al. Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development. Blood. 2021;138(17):1583-1589doi: 10.1182/blood.2020009754.
Alameda, D., Goicoechea, I., Vicari, M., Arriazu, E., Nevone, A., Rodriguez, S., Lasa, M., Puig, N., Cedena, M. T., Alignani, D., Garate, S., Lara-Astiaso, D., Vilas-Zornoza, A., Sarvide, S., Ocio, E. M., Lecumberri, R., Garcia de Coca, A., Labrador, J., Gonzalez, M. E., Palomera, L., Gironella, M., Cabañas, V., Casanova, M., Oriol, A., Krsnik, I., Perez-Montaña, A., de la Rubia, J., de la Puerta, J. E., de Arriba, F., Fazio, V. M., Martinez-Lopez, J., Lahuerta, J. J., Mateos, M. V., Odero, M. D., Prosper, F., Weiner, A., Amit, I., Nuvolone, M., San Miguel, J. F., & Paiva, B. (2021). Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development. Blood, 138(17), 1583-1589. https://doi.org/10.1182/blood.2020009754
Alameda, Daniel, et al. "Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development." Blood vol. 138,17 (2021): 1583-1589. doi: https://doi.org/10.1182/blood.2020009754
Alameda D, Goicoechea I, Vicari M, Arriazu E, Nevone A, Rodriguez S, Lasa M, Puig N, Cedena MT, Alignani D, Garate S, Lara-Astiaso D, Vilas-Zornoza A, Sarvide S, Ocio EM, Lecumberri R, Garcia de Coca A, Labrador J, Gonzalez ME, Palomera L, Gironella M, Cabañas V, Casanova M, Oriol A, Krsnik I, Perez-Montaña A, de la Rubia J, de la Puerta JE, de Arriba F, Fazio VM, Martinez-Lopez J, Lahuerta JJ, Mateos MV, Odero MD, Prosper F, Weiner A, Amit I, Nuvolone M, San Miguel JF, Paiva B. Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development. Blood. 2021 Oct 28;138(17):1583-1589. doi: 10.1182/blood.2020009754. PMID: 34133718.
Copy Download .nbib Format: NLM
Impact of .

Pharmacogenomics and personalized medicine

Torres-Valadez R, Ramos-Lopez O, Frías Delgadillo KJ, Flores-García A, Rojas Carrillo E, Aguiar-García P, Bernal Pérez JA, Martinez-Lopez E, Martínez JA, Zepeda-Carrillo EA.
PMID: 33273843
Pharmgenomics Pers Med. 2020 Nov 26;13:655-663. doi: 10.2147/PGPM.S277952. eCollection 2020.

PURPOSE: To analyze clinically relevant interactions between the apolipoprotein E (PATIENTS AND METHODS: In this cross-sectional study of the cohort of T2D patients, a total of 224 individuals were selected for interaction studies. Clinical and anthropometric data were obtained...

Cite
Torres-Valadez R, Ramos-Lopez O, Frías Delgadillo KJ, et al. Impact of . Pharmgenomics Pers Med. 2020;13:655-663doi: 10.2147/PGPM.S277952.
Torres-Valadez, R., Ramos-Lopez, O., Frías Delgadillo, K. J., Flores-García, A., Rojas Carrillo, E., Aguiar-García, P., Bernal Pérez, J. A., Martinez-Lopez, E., Martínez, J. A., & Zepeda-Carrillo, E. A. (2020). Impact of . Pharmacogenomics and personalized medicine, 13655-663. https://doi.org/10.2147/PGPM.S277952
Torres-Valadez, Rafael, et al. "Impact of ." Pharmacogenomics and personalized medicine vol. 13 (2020): 655-663. doi: https://doi.org/10.2147/PGPM.S277952
Torres-Valadez R, Ramos-Lopez O, Frías Delgadillo KJ, Flores-García A, Rojas Carrillo E, Aguiar-García P, Bernal Pérez JA, Martinez-Lopez E, Martínez JA, Zepeda-Carrillo EA. Impact of . Pharmgenomics Pers Med. 2020 Nov 26;13:655-663. doi: 10.2147/PGPM.S277952. eCollection 2020. PMID: 33273843; PMCID: PMC7705254.
Copy Download .nbib Format: NLM
C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids.

Modern rheumatology

Yoshida Y, Sugimoto T, Hosokawa Y, Suma H, Kobayashi H, Ishitoku M, Kohno H, Tokunaga T, Watanabe H, Mokuda S, Nojima T, Hirata S, Sugiyama E, Martinez-Lopez R.
PMID: 34922405
Mod Rheumatol. 2021 Apr 15; doi: 10.1080/14397595.2021.1907014. Epub 2021 Apr 15.

OBJECTIVES: Cyclophosphamide (CYC) has been proposed as a standard induction regimen for interstitial lung disease (ILD) associated with systemic sclerosis (SSc). However, there remain patients with SSc-ILD who are intractable to the therapy. This study aimed to identify factors...

Cite
Yoshida Y, Sugimoto T, Hosokawa Y, et al. C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids. Mod Rheumatol. 2021;doi: 10.1080/14397595.2021.1907014.
Yoshida, Y., Sugimoto, T., Hosokawa, Y., Suma, H., Kobayashi, H., Ishitoku, M., Kohno, H., Tokunaga, T., Watanabe, H., Mokuda, S., Nojima, T., Hirata, S., Sugiyama, E., & Martinez-Lopez, R. (2021). C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids. Modern rheumatology, . https://doi.org/10.1080/14397595.2021.1907014
Yoshida, Yusuke, et al. "C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids." Modern rheumatology vol. (2021). doi: https://doi.org/10.1080/14397595.2021.1907014
Yoshida Y, Sugimoto T, Hosokawa Y, Suma H, Kobayashi H, Ishitoku M, Kohno H, Tokunaga T, Watanabe H, Mokuda S, Nojima T, Hirata S, Sugiyama E, Martinez-Lopez R. C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids. Mod Rheumatol. 2021 Apr 15; doi: 10.1080/14397595.2021.1907014. Epub 2021 Apr 15. PMID: 34922405.
Copy Download .nbib Format: NLM
Multi-element comparisons of tapes evidence using dimensionality reduction for calculating likelihood ratios.

Forensic science international

Gupta A, Martinez-Lopez C, Curran JM, Almirall JR.
PMID: 31229846
Forensic Sci Int. 2019 Aug;301:426-434. doi: 10.1016/j.forsciint.2019.06.002. Epub 2019 Jun 12.

Computing the likelihood ratio (LR), as a measure of weight of evidence, has traditionally been difficult for multi-element evidence. A solution based on multivariate random effects models has been adopted by the forensic community but suffers from instability and...

Cite
Gupta A, Martinez-Lopez C, Curran JM, et al. Multi-element comparisons of tapes evidence using dimensionality reduction for calculating likelihood ratios. Forensic Sci Int. 2019;301:426-434doi: 10.1016/j.forsciint.2019.06.002.
Gupta, A., Martinez-Lopez, C., Curran, J. M., & Almirall, J. R. (2019). Multi-element comparisons of tapes evidence using dimensionality reduction for calculating likelihood ratios. Forensic science international, 301426-434. https://doi.org/10.1016/j.forsciint.2019.06.002
Gupta, Anjali, et al. "Multi-element comparisons of tapes evidence using dimensionality reduction for calculating likelihood ratios." Forensic science international vol. 301 (2019): 426-434. doi: https://doi.org/10.1016/j.forsciint.2019.06.002
Gupta A, Martinez-Lopez C, Curran JM, Almirall JR. Multi-element comparisons of tapes evidence using dimensionality reduction for calculating likelihood ratios. Forensic Sci Int. 2019 Aug;301:426-434. doi: 10.1016/j.forsciint.2019.06.002. Epub 2019 Jun 12. PMID: 31229846.
Copy Download .nbib Format: NLM
Surveillance for Enteroviruses Associated with Hand, Foot, and Mouth Disease, and Other Mucocutaneous Symptoms in Spain, 2006-2020.

Viruses

Martínez-López N, Muñoz-Almagro C, Launes C, Navascués A, Imaz-Pérez M, Reina J, Romero MP, Calvo C, Ruiz-García M, Megias G, Valencia-Ramos J, Otero A, Cabrerizo M.
PMID: 33924875
Viruses. 2021 Apr 28;13(5). doi: 10.3390/v13050781.

Hand, foot, and mouth disease (HFMD) is a mild illness caused by enteroviruses (EV), although in some Asian countries, large outbreaks have been reported in the last 25 years, with a considerable incidence of neurological complications. This study describes...

Cite
Martínez-López N, Muñoz-Almagro C, Launes C, et al. Surveillance for Enteroviruses Associated with Hand, Foot, and Mouth Disease, and Other Mucocutaneous Symptoms in Spain, 2006-2020. Viruses. 2021;13(5)doi: 10.3390/v13050781.
Martínez-López, N., Muñoz-Almagro, C., Launes, C., Navascués, A., Imaz-Pérez, M., Reina, J., Romero, M. P., Calvo, C., Ruiz-García, M., Megias, G., Valencia-Ramos, J., Otero, A., & Cabrerizo, M. (2021). Surveillance for Enteroviruses Associated with Hand, Foot, and Mouth Disease, and Other Mucocutaneous Symptoms in Spain, 2006-2020. Viruses, 13(5), . https://doi.org/10.3390/v13050781
Martínez-López, Nieves, et al. "Surveillance for Enteroviruses Associated with Hand, Foot, and Mouth Disease, and Other Mucocutaneous Symptoms in Spain, 2006-2020." Viruses vol. 13,5 (2021). doi: https://doi.org/10.3390/v13050781
Martínez-López N, Muñoz-Almagro C, Launes C, Navascués A, Imaz-Pérez M, Reina J, Romero MP, Calvo C, Ruiz-García M, Megias G, Valencia-Ramos J, Otero A, Cabrerizo M. Surveillance for Enteroviruses Associated with Hand, Foot, and Mouth Disease, and Other Mucocutaneous Symptoms in Spain, 2006-2020. Viruses. 2021 Apr 28;13(5). doi: 10.3390/v13050781. PMID: 33924875; PMCID: PMC8146579.
Copy Download .nbib Format: NLM
High dietary ω-6:ω-3 PUFA ratio and simple carbohydrates as a potential risk factors for gallstone disease: A cross-sectional study.

Clinics and research in hepatology and gastroenterology

Campos-Perez W, Perez-Robles M, Rodriguez-Echevarria R, Rivera-Valdés JJ, Rodríguez-Navarro FM, Rivera-Leon EA, Martinez-Lopez E.
PMID: 34896648
Clin Res Hepatol Gastroenterol. 2021 Dec 09;101802. doi: 10.1016/j.clinre.2021.101802. Epub 2021 Dec 09.

BACKGROUND & AIMS: Gallstone disease (GD) is a major cause for consultation at general surgery services worldwide. In fact, GD has a strong relationship with environmental factors. However, specific characteristics in the Mexican population have not been established. The...

Cite
Campos-Perez W, Perez-Robles M, Rodriguez-Echevarria R, et al. High dietary ω-6:ω-3 PUFA ratio and simple carbohydrates as a potential risk factors for gallstone disease: A cross-sectional study. Clin Res Hepatol Gastroenterol. 2021;101802doi: 10.1016/j.clinre.2021.101802.
Campos-Perez, W., Perez-Robles, M., Rodriguez-Echevarria, R., Rivera-Valdés, J. J., Rodríguez-Navarro, F. M., Rivera-Leon, E. A., & Martinez-Lopez, E. (2021). High dietary ω-6:ω-3 PUFA ratio and simple carbohydrates as a potential risk factors for gallstone disease: A cross-sectional study. Clinics and research in hepatology and gastroenterology, 101802. https://doi.org/10.1016/j.clinre.2021.101802
Campos-Perez, Wendy, et al. "High dietary ω-6:ω-3 PUFA ratio and simple carbohydrates as a potential risk factors for gallstone disease: A cross-sectional study." Clinics and research in hepatology and gastroenterology vol. (2021): 101802. doi: https://doi.org/10.1016/j.clinre.2021.101802
Campos-Perez W, Perez-Robles M, Rodriguez-Echevarria R, Rivera-Valdés JJ, Rodríguez-Navarro FM, Rivera-Leon EA, Martinez-Lopez E. High dietary ω-6:ω-3 PUFA ratio and simple carbohydrates as a potential risk factors for gallstone disease: A cross-sectional study. Clin Res Hepatol Gastroenterol. 2021 Dec 09;101802. doi: 10.1016/j.clinre.2021.101802. Epub 2021 Dec 09. PMID: 34896648.
Copy Download .nbib Format: NLM
Looking for Crumbs in the Obesity Forest: Anti-obesity Interventions and Obesity-Associated Cardiometabolic Traits in the Mexican Population. History and Systematic Review With Meta-Analyses.

Frontiers in medicine

Garcia-Oropesa EM, Martinez-Lopez YE, Ruiz-Cejudo SM, Martínez-Ezquerro JD, Diaz-Badillo A, Ramirez-Pfeiffer C, Bustamante-Fuentes A, Lopez-Sosa EB, Moctezuma-Chavez OO, Nava-Gonzalez EJ, Perales-Torres AL, Perez-Navarro LM, Rosas-Diaz M, Carter K, Tapia B, Lopez-Alvarenga JC.
PMID: 34805192
Front Med (Lausanne). 2021 Nov 03;8:665023. doi: 10.3389/fmed.2021.665023. eCollection 2021.

Mexicans and Mexican Americans share culture, genetic background, and predisposition for chronic complications associated with obesity and diabetes making imperative efficacious treatments and prevention. Obesity has been treated for centuries focused-on weight loss while other treatments on associated conditions...

Cite
Garcia-Oropesa EM, Martinez-Lopez YE, Ruiz-Cejudo SM, et al. Looking for Crumbs in the Obesity Forest: Anti-obesity Interventions and Obesity-Associated Cardiometabolic Traits in the Mexican Population. History and Systematic Review With Meta-Analyses. Front Med (Lausanne). 2021;8:665023doi: 10.3389/fmed.2021.665023.
Garcia-Oropesa, E. M., Martinez-Lopez, Y. E., Ruiz-Cejudo, S. M., Martínez-Ezquerro, J. D., Diaz-Badillo, A., Ramirez-Pfeiffer, C., Bustamante-Fuentes, A., Lopez-Sosa, E. B., Moctezuma-Chavez, O. O., Nava-Gonzalez, E. J., Perales-Torres, A. L., Perez-Navarro, L. M., Rosas-Diaz, M., Carter, K., Tapia, B., & Lopez-Alvarenga, J. C. (2021). Looking for Crumbs in the Obesity Forest: Anti-obesity Interventions and Obesity-Associated Cardiometabolic Traits in the Mexican Population. History and Systematic Review With Meta-Analyses. Frontiers in medicine, 8665023. https://doi.org/10.3389/fmed.2021.665023
Garcia-Oropesa, Esperanza M, et al. "Looking for Crumbs in the Obesity Forest: Anti-obesity Interventions and Obesity-Associated Cardiometabolic Traits in the Mexican Population. History and Systematic Review With Meta-Analyses." Frontiers in medicine vol. 8 (2021): 665023. doi: https://doi.org/10.3389/fmed.2021.665023
Garcia-Oropesa EM, Martinez-Lopez YE, Ruiz-Cejudo SM, Martínez-Ezquerro JD, Diaz-Badillo A, Ramirez-Pfeiffer C, Bustamante-Fuentes A, Lopez-Sosa EB, Moctezuma-Chavez OO, Nava-Gonzalez EJ, Perales-Torres AL, Perez-Navarro LM, Rosas-Diaz M, Carter K, Tapia B, Lopez-Alvarenga JC. Looking for Crumbs in the Obesity Forest: Anti-obesity Interventions and Obesity-Associated Cardiometabolic Traits in the Mexican Population. History and Systematic Review With Meta-Analyses. Front Med (Lausanne). 2021 Nov 03;8:665023. doi: 10.3389/fmed.2021.665023. eCollection 2021. PMID: 34805192; PMCID: PMC8595206.
Copy Download .nbib Format: NLM
ECG of the month. A fly in the ointment. Acute myocardial infarction.

The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society

Martinez-Lopez JI.
PMID: 3221132
J La State Med Soc. 1988 Dec;140(12):13, 15-6.

No abstract available.

Cite
Martinez-Lopez JI. ECG of the month. A fly in the ointment. Acute myocardial infarction. J La State Med Soc. 1988;140(12):13, 15-6
Martinez-Lopez, J. I. (1988). ECG of the month. A fly in the ointment. Acute myocardial infarction. The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 140(12), 13, 15-6.
Martinez-Lopez, J I. "ECG of the month. A fly in the ointment. Acute myocardial infarction." The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society vol. 140,12 (1988): 13, 15-6.
Martinez-Lopez JI. ECG of the month. A fly in the ointment. Acute myocardial infarction. J La State Med Soc. 1988 Dec;140(12):13, 15-6. PMID: 3221132.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 68 entries